|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DURA PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
Next: DURA PHARMACEUTICALS INC, 10-Q, EX-27, 2000-11-14 |
<PAGE>
EXHIBIT 11
DURA PHARMACEUTICALS, INC.
STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
IN THOUSANDS, EXCEPT PER SHARE AMOUNTS
(UNAUDITED)
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
2000 1999 2000 1999
-----------------------------------------------------------------------
<S> <C> <C> <C> <C>
NET INCOME (LOSS) PER SHARE - BASIC
Net Income (Loss) $ (98,700) $ 3,536 $ (76,801) $ 18,884
=========== ========== =========== ==========
Weighted average number of common shares:
Common stock 44,767 44,138 44,478 44,107
=========== ========== =========== ==========
Net Income (Loss) per Share $ (2.20) $ 0.08 $ (1.73) $ 0.43
=========== ========== =========== ==========
NET INCOME (LOSS) PER SHARE - DILUTED
Net Income (Loss) $ (98,700) $ 3,536 $ (76,801) $ 18,884
=========== ========== =========== ==========
Weighted average number of common and
common equivalent shares assuming
issuance of all dilutive contingent shares:
Common stock 44,767 44,138 44,478 44,107
Stock options 707 905
Warrants 617 643
----------- ---------- ----------- ----------
Total 44,767 45,462 44,478 45,655
=========== ========== =========== ==========
Net Income (Loss) per Share $ (2.20) $ 0.08 $ (1.73) $ 0.41
=========== ========== =========== ==========
</TABLE>
|
|